Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.07 trillion and total revenue of $110.08 billion.
Market Cap
1.07T
Revenue
110.08B
Profits
-41.19B
PE Ratio
n/a
Profit Margin
-37.42%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.27B | -0.27% | 1,157,739 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.00B | 0.97% | 488,334 | 14.34B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.52B | -0.16% | 1,119,574 | 3.71B |
| 4 | ARGX | argenx SE | 42.87B | -0.61% | 268,847 | 4.24B |
| 5 | INSM | Insmed Incorporated | 31.82B | -0.48% | 2,587,279 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 30.70B | -2.29% | 238,581 | 5.34B |
| 7 | BNTX | BioNTech SE | 21.98B | -1.48% | 686,370 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 21.16B | 0.06% | 3,356,394 | 1.94B |
| 9 | RPRX | Royalty Pharma plc | 20.11B | -0.19% | 3,216,478 | 2.38B |
| 10 | ROIV | Roivant Sciences Ltd. | 19.57B | -0.04% | 3,222,089 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 18.47B | -1.15% | 1,703,014 | - |
| 12 | INCY | Incyte Corporation | 18.36B | 0.03% | 1,229,455 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.05B | -0.31% | 3,059,856 | 3.72B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.07B | 1.35% | 1,493,505 | 502.08M |
| 15 | ASND | Ascendis Pharma A/S | 13.54B | -0.14% | 388,182 | 845.52M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.38B | -3.79% | 4,343,164 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.26B | 2.12% | 4,202,355 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | 12.30% | 1,373,257 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.64B | 0.04% | 886,443 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.00B | -0.99% | 1,703,307 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.68B | -0.07% | 939,854 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 8.60B | -1.10% | 848,132 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.51B | - | 2,662,461 | 1.09B |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.43B | -2.96% | 419,892 | 7.46M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.40B | 1.54% | 304,365 | 638.50M |
| 26 | TECH | Bio-Techne Corporation | 8.25B | 0.02% | 1,492,659 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 7.87B | -2.15% | 871,457 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 7.82B | 1.74% | 2,201,526 | 88.04M |
| 29 | NUVL | Nuvalent, Inc. | 7.71B | 0.06% | 478,378 | - |
| 30 | IBRX | ImmunityBio, Inc. | 7.59B | -8.55% | 26,480,344 | 113.29M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.47B | 0.08% | 730,060 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.35B | -1.39% | 281,867 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.70B | 0.07% | 1,204,437 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.55B | 1.58% | 773,984 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.52B | -2.05% | 1,045,268 | 46.02M |
| 36 | COGT | Cogent Biosciences, Inc. | 5.98B | 1.01% | 1,170,214 | - |
| 37 | BLTE | Belite Bio, Inc | 5.87B | -3.78% | 141,286 | - |
| 38 | CGON | CG Oncology, Inc. | 5.63B | 1.31% | 783,077 | 4.04M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.59B | -3.21% | 932,714 | 189.76M |
| 40 | CELC | Celcuity Inc. | 5.55B | 4.16% | 1,360,311 | - |
| 41 | PTCT | PTC Therapeutics, Inc. | 5.55B | 0.37% | 659,170 | 1.73B |
| 42 | APGE | Apogee Therapeutics, Inc. | 5.45B | -0.14% | 1,147,666 | - |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.36B | -1.43% | 672,820 | 521.31M |
| 44 | XENE | Xenon Pharmaceuticals Inc. | 5.30B | -0.07% | 1,054,987 | 7.50M |
| 45 | CAI | Caris Life Sciences, Inc. | 5.18B | -1.24% | 1,269,420 | 812.03M |
| 46 | IMVT | Immunovant, Inc. | 5.16B | 2.42% | 1,035,282 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 5.11B | 0.50% | 1,839,511 | 616.29M |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.08B | -2.69% | 1,940,534 | - |
| 49 | TERN | Terns Pharmaceuticals, Inc. | 4.79B | 0.59% | 19,735,410 | - |
| 50 | ERAS | Erasca, Inc. | 4.71B | -5.19% | 3,843,725 | - |
| 51 | CRSP | CRISPR Therapeutics AG | 4.56B | 0.98% | 1,262,192 | 3.51M |
| 52 | FOLD | Amicus Therapeutics, Inc. | 4.53B | -0.07% | 1,563,907 | 634.21M |
| 53 | CORT | Corcept Therapeutics Incorporated | 4.10B | -4.79% | 3,032,882 | 761.41M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.06B | -0.42% | 214,302 | 268.09M |
| 55 | VKTX | Viking Therapeutics, Inc. | 3.96B | 3.16% | 2,239,536 | - |
| 56 | CNTA | Centessa Pharmaceuticals plc | 3.95B | 4.18% | 1,867,960 | 15.00M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.80B | -0.08% | 1,212,315 | 7.70M |
| 58 | SYRE | Spyre Therapeutics, Inc. | 3.73B | 4.03% | 1,332,501 | - |
| 59 | DNTH | Dianthus Therapeutics, Inc. | 3.67B | 3.57% | 1,560,164 | 2.04M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 3.66B | -2.45% | 1,466,172 | 1.07B |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.59B | 0.77% | 493,523 | 22.50M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.40B | -0.91% | 446,325 | - |
| 63 | ALMS | Alumis Inc. | 3.35B | 6.09% | 981,568 | 24.05M |
| 64 | GPCR | Structure Therapeutics Inc. | 3.27B | -4.01% | 701,875 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.23B | -0.63% | 1,478,249 | 1.03B |
| 66 | DNLI | Denali Therapeutics Inc. | 3.13B | -12.17% | 3,425,191 | - |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.06B | -2.27% | 1,569,528 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.04B | 0.79% | 332,367 | 803.79M |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.96B | 1.89% | 779,281 | 588.99M |
| 70 | VRDN | Viridian Therapeutics, Inc. | 2.88B | -0.53% | 908,324 | 70.85M |
| 71 | VERA | Vera Therapeutics, Inc. | 2.87B | 0.25% | 625,621 | - |
| 72 | TARS | Tarsus Pharmaceuticals, Inc. | 2.86B | 0.36% | 689,741 | 451.36M |
| 73 | TNGX | Tango Therapeutics, Inc. | 2.83B | -4.89% | 2,745,901 | 62.38M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.82B | 2.23% | 680,390 | 218.71M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.78B | -1.58% | 470,144 | 376.07M |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.66B | -1.16% | 950,592 | 247.00M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.58B | 1.31% | 850,993 | 490.73M |
| 78 | MANE | Veradermics, Incorporated | 2.52B | 3.04% | 388,185 | - |
| 79 | BEAM | Beam Therapeutics Inc. | 2.41B | 2.16% | 2,294,643 | 139.74M |
| 80 | IRON | Disc Medicine, Inc. | 2.37B | -0.86% | 292,734 | - |
| 81 | ELVN | Enliven Therapeutics, Inc. | 2.35B | 10.58% | 3,233,704 | - |
| 82 | IMNM | Immunome, Inc. | 2.31B | 0.54% | 1,305,693 | 6.94M |
| 83 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | -8.79% | 7,017,143 | 2.20B |
| 84 | APLS | Apellis Pharmaceuticals, Inc. | 2.25B | -0.45% | 1,662,092 | 1.00B |
| 85 | ORKA | Oruka Therapeutics, Inc. | 2.25B | 3.77% | 1,558,410 | - |
| 86 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.14% | 3,308,554 | 158.18M |
| 87 | SNDX | Syndax Pharmaceuticals, Inc. | 2.18B | 2.07% | 1,293,265 | 172.35M |
| 88 | ADPT | Adaptive Biotechnologies Corporation | 2.15B | -1.34% | 1,217,971 | 276.98M |
| 89 | CLDX | Celldex Therapeutics, Inc. | 2.11B | 0.22% | 762,607 | 1.55M |
| 90 | KOD | Kodiak Sciences Inc. | 2.11B | 74.77% | 13,142,712 | - |
| 91 | TYRA | Tyra Biosciences, Inc. | 2.05B | 3.60% | 531,603 | - |
| 92 | NKTR | Nektar Therapeutics | 2.04B | -1.54% | 866,807 | 55.23M |
| 93 | STOK | Stoke Therapeutics, Inc. | 1.99B | -0.27% | 2,964,550 | 184.42M |
| 94 | AAPG | Ascentage Pharma Group International | 1.98B | -4.84% | 1,754 | 54.52M |
| 95 | GLPG | Galapagos NV | 1.97B | -2.19% | 176,108 | 1.31B |
| 96 | ADMA | ADMA Biologics, Inc. | 1.97B | -13.91% | 34,169,327 | 510.17M |
| 97 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | -4.10% | 629,447 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.94B | 1.60% | 918,471 | 283.06M |
| 99 | ZLAB | Zai Lab Limited | 1.94B | -4.26% | 933,047 | 460.16M |
| 100 | RARE | Ultragenyx Pharmaceutical Inc. | 1.93B | 0.76% | 2,286,771 | 673.00M |
| 101 | MESO | Mesoblast Limited | 1.91B | -5.18% | 118,821 | 65.38M |
| 102 | DFTX | Definium Therapeutics, Inc. | 1.89B | 2.54% | 1,396,229 | - |
| 103 | ANAB | AnaptysBio, Inc. | 1.87B | -0.61% | 252,619 | 234.60M |
| 104 | ZYME | Zymeworks Inc. | 1.82B | 1.90% | 388,133 | 105.97M |
| 105 | RLAY | Relay Therapeutics, Inc. | 1.81B | 5.42% | 4,014,610 | 15.36M |
| 106 | OCUL | Ocular Therapeutix, Inc. | 1.76B | -3.12% | 3,679,777 | 51.95M |
| 107 | AGIO | Agios Pharmaceuticals, Inc. | 1.75B | 1.22% | 1,129,847 | 54.03M |
| 108 | CAPR | Capricor Therapeutics, Inc. | 1.72B | 0.17% | 696,069 | 11.13M |
| 109 | SION | Sionna Therapeutics, Inc. | 1.71B | 2.37% | 273,830 | - |
| 110 | INVA | Innoviva, Inc. | 1.68B | 0.31% | 691,775 | 411.33M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | -0.63% | 9,507,592 | 74.68M |
| 112 | SLNO | Soleno Therapeutics, Inc. | 1.64B | 0.06% | 1,752,558 | 190.41M |
| 113 | GENB | Generate Biomedicines, Inc. | 1.64B | 8.62% | 451,757 | 31.89M |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.60B | 0.58% | 1,203,218 | 83.98M |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.59B | -0.54% | 657,190 | 868.45M |
| 116 | MAZE | Maze Therapeutics, Inc. | 1.58B | -0.06% | 1,716,865 | 2.50M |
| 117 | VCEL | Vericel Corporation | 1.56B | -1.97% | 747,229 | 276.26M |
| 118 | NTLA | Intellia Therapeutics, Inc. | 1.56B | -0.15% | 5,711,529 | 67.67M |
| 119 | IMCR | Immunocore Holdings plc | 1.55B | 0.76% | 248,114 | 400.02M |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.55B | 2.32% | 260,498 | - |
| 121 | NUVB | Nuvation Bio Inc. | 1.54B | 0.91% | 2,033,392 | 62.90M |
| 122 | IOVA | Iovance Biotherapeutics, Inc. | 1.52B | -1.60% | 7,470,992 | 263.50M |
| 123 | NBTX | Nanobiotix S.A. | 1.52B | 2.25% | 72,005 | 11.93M |
| 124 | TRVI | Trevi Therapeutics, Inc. | 1.52B | 3.15% | 1,384,848 | - |
| 125 | PHVS | Pharvaris N.V. | 1.50B | 5.05% | 454,858 | - |
| 126 | OCS | Oculis Holding AG | 1.48B | -0.04% | 105,854 | 1.51M |
| 127 | NVAX | Novavax, Inc. | 1.46B | -4.18% | 3,064,287 | 1.12B |
| 128 | ARDX | Ardelyx, Inc. | 1.40B | 0.89% | 2,921,665 | 407.32M |
| 129 | PVLA | Palvella Therapeutics, Inc. | 1.39B | -2.31% | 153,842 | - |
| 130 | RAPP | Rapport Therapeutics, Inc. | 1.39B | 0.38% | 325,464 | - |
| 131 | PGEN | Precigen, Inc. | 1.38B | 25.48% | 23,491,245 | 9.68M |
| 132 | MBX | MBX Biosciences, Inc. | 1.34B | -2.31% | 236,940 | - |
| 133 | BHVN | Biohaven Ltd. | 1.34B | 3.60% | 1,717,375 | - |
| 134 | IMTX | Immatics N.V. | 1.31B | 0.31% | 292,953 | 56.67M |
| 135 | ATAI | AtaiBeckley Inc. | 1.29B | - | 2,607,669 | 4.09M |
| 136 | MLTX | MoonLake Immunotherapeutics | 1.27B | -1.50% | 1,348,329 | - |
| 137 | ZBIO | Zenas BioPharma, Inc. | 1.27B | -0.14% | 234,661 | 10.00M |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.25B | -0.25% | 721,363 | 123.67M |
| 139 | VIR | Vir Biotechnology, Inc. | 1.25B | -0.33% | 2,029,473 | 68.56M |
| 140 | ORIC | ORIC Pharmaceuticals, Inc. | 1.24B | 5.81% | 1,743,101 | - |
| 141 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | -5.68% | 2,328,196 | 9.77M |
| 142 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | -0.35% | 758,905 | - |
| 143 | DBVT | DBV Technologies S.A. | 1.20B | -0.30% | 200,324 | 5.50M |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -1.05% | 982,081 | - |
| 145 | WVE | Wave Life Sciences Ltd. | 1.17B | -49.59% | 50,126,541 | 42.73M |
| 146 | PHAR | Pharming Group N.V. | 1.12B | 0.49% | 4,991 | 376.13M |
| 147 | SEPN | Septerna, Inc. | 1.11B | 2.19% | 238,774 | 45.95M |
| 148 | EYPT | EyePoint, Inc. | 1.09B | 0.08% | 767,892 | 31.37M |
| 149 | SVRA | Savara Inc. | 1.07B | -0.57% | 1,097,100 | - |
| 150 | BCAX | Bicara Therapeutics Inc. | 1.04B | 1.28% | 414,103 | - |
| 151 | ABCL | AbCellera Biologics Inc. | 1.02B | -1.18% | 1,779,271 | 75.13M |
| 152 | GERN | Geron Corporation | 986.44M | -1.91% | 19,699,281 | 183.88M |
| 153 | QURE | uniQure N.V. | 975.46M | -4.65% | 1,588,220 | 16.10M |
| 154 | AVBP | ArriVent BioPharma, Inc. | 963.82M | -4.15% | 229,724 | - |
| 155 | TVGN | Tevogen Bio Holdings Inc. | 963.50M | -8.11% | 58,332 | - |
| 156 | INBX | Inhibrx Biosciences, Inc. | 961.00M | -1.01% | 212,599 | 1.30M |
| 157 | XERS | Xeris Biopharma Holdings, Inc. | 960.44M | 5.09% | 2,176,550 | 291.85M |
| 158 | CMPX | Compass Therapeutics, Inc. | 959.87M | -2.91% | 1,140,876 | 850.00K |
| 159 | KALV | KalVista Pharmaceuticals, Inc. | 957.85M | 10.56% | 2,400,755 | 73.62M |
| 160 | AKTS | Aktis Oncology, Inc. | 925.44M | -5.47% | 217,014 | 5.56M |
| 161 | XNCR | Xencor, Inc. | 902.80M | -0.73% | 811,289 | 125.58M |
| 162 | FTRE | Fortrea Holdings Inc. | 892.93M | 1.17% | 963,831 | 2.72B |
| 163 | SLS | SELLAS Life Sciences Group, Inc. | 888.93M | -6.60% | 5,654,406 | - |
| 164 | GHRS | GH Research PLC | 873.99M | 3.22% | 224,850 | - |
| 165 | URGN | UroGen Pharma Ltd. | 871.41M | -1.21% | 326,910 | 109.79M |
| 166 | ABUS | Arbutus Biopharma Corporation | 869.88M | -1.77% | 1,497,345 | 14.08M |
| 167 | EVMN | Evommune, Inc. | 852.55M | 2.33% | 275,288 | 13.00M |
| 168 | PHAT | Phathom Pharmaceuticals, Inc. | 850.24M | 3.06% | 762,897 | 175.11M |
| 169 | SPRY | ARS Pharmaceuticals, Inc. | 849.98M | 8.35% | 1,898,249 | 84.28M |
| 170 | IVA | Inventiva S.A. | 847.43M | 1.16% | 348,084 | 19.93M |
| 171 | SGP | SpyGlass Pharma, Inc. | 839.60M | -0.08% | 87,229 | - |
| 172 | MPLT | MapLight Therapeutics, Inc. | 839.22M | 6.01% | 295,127 | - |
| 173 | JANX | Janux Therapeutics, Inc. | 829.14M | -1.23% | 1,256,089 | 10.00M |
| 174 | CGEM | Cullinan Therapeutics, Inc. | 827.39M | -2.77% | 659,777 | - |
| 175 | SANA | Sana Biotechnology, Inc. | 808.61M | -2.26% | 1,792,563 | - |
| 176 | TBPH | Theravance Biopharma, Inc. | 782.18M | -0.65% | 387,488 | 107.46M |
| 177 | SLDB | Solid Biosciences Inc. | 760.56M | 6.92% | 1,149,690 | - |
| 178 | CTMX | CytomX Therapeutics, Inc. | 750.52M | 4.74% | 6,272,740 | 76.20M |
| 179 | ANL | Adlai Nortye Ltd. | 747.23M | -5.20% | 151,143 | -1.35M |
| 180 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 738.70M | -0.22% | 68,884 | - |
| 181 | KURA | Kura Oncology, Inc. | 738.44M | -2.22% | 1,200,767 | 67.48M |
| 182 | OMER | Omeros Corporation | 730.27M | -1.34% | 553,034 | - |
| 183 | DRUG | Bright Minds Biosciences Inc. | 716.19M | -1.07% | 103,389 | - |
| 184 | MNKD | MannKind Corporation | 708.63M | 0.88% | 6,354,598 | 348.97M |
| 185 | ARVN | Arvinas, Inc. | 695.26M | -0.46% | 416,276 | 262.60M |
| 186 | LXRX | Lexicon Pharmaceuticals, Inc. | 690.60M | -2.98% | 3,670,451 | 49.80M |
| 187 | JBIO | Jade Biosciences, Inc. | 687.96M | - | 181,106 | - |
| 188 | RLMD | Relmada Therapeutics, Inc. | 684.93M | -1.95% | 1,037,287 | - |
| 189 | GYRE | Gyre Therapeutics, Inc. | 682.62M | -1.95% | 91,541 | 116.59M |
| 190 | ANRO | Alto Neuroscience, Inc. | 665.11M | 0.73% | 211,465 | - |
| 191 | DSGN | Design Therapeutics, Inc. | 660.51M | -0.19% | 131,398 | - |
| 192 | PRME | Prime Medicine, Inc. | 657.21M | 0.28% | 1,804,153 | 4.63M |
| 193 | OCGN | Ocugen, Inc. | 642.68M | 0.51% | 7,579,548 | 4.41M |
| 194 | ANNX | Annexon, Inc. | 628.07M | -2.14% | 2,848,929 | - |
| 195 | REPL | Replimune Group, Inc. | 622.60M | -0.26% | 1,086,953 | - |
| 196 | LBRX | LB Pharmaceuticals Inc | 620.59M | 1.32% | 212,049 | - |
| 197 | DRTS | Alpha Tau Medical Ltd. | 607.27M | -2.27% | 181,785 | - |
| 198 | MGTX | MeiraGTx Holdings plc | 606.10M | -1.18% | 1,000,118 | 81.39M |
| 199 | ALLO | Allogene Therapeutics, Inc. | 587.50M | 3.43% | 5,247,331 | 22.00K |
| 200 | MDXG | MiMedx Group, Inc. | 585.35M | -3.90% | 1,126,150 | 418.63M |
| 201 | AGMB | AgomAb Therapeutics NV | 578.51M | -7.70% | 124,282 | - |
| 202 | TECX | Tectonic Therapeutic, Inc. | 577.57M | -0.97% | 129,759 | - |
| 203 | ZURA | Zura Bio Limited | 573.08M | 7.47% | 509,263 | - |
| 204 | EIKN | Eikon Therapeutics, Inc. | 568.46M | -4.88% | 454,257 | - |
| 205 | YDES | YD Bio Limited | 560.24M | 4.01% | 11,292 | 510.36K |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 551.89M | 2.96% | 675,922 | 106.47M |
| 207 | VALN | Valneva SE | 547.99M | -2.47% | 112,808 | 205.07M |
| 208 | UPB | Upstream Bio, Inc. | 532.77M | 3.38% | 883,196 | 2.85M |
| 209 | CRMD | CorMedix Inc. | 529.64M | 1.36% | 970,412 | 311.71M |
| 210 | FDMT | 4D Molecular Therapeutics, Inc. | 519.70M | 3.04% | 2,235,070 | 85.21M |
| 211 | PRTA | Prothena Corporation plc | 512.49M | 2.26% | 452,594 | 9.68M |
| 212 | CTNM | Contineum Therapeutics, Inc. | 509.64M | 2.79% | 137,758 | - |
| 213 | RCKT | Rocket Pharmaceuticals, Inc. | 509.19M | 0.21% | 6,957,426 | - |
| 214 | LRMR | Larimar Therapeutics, Inc. | 503.83M | 3.63% | 1,200,678 | - |
| 215 | ADCT | ADC Therapeutics SA | 503.10M | -0.25% | 419,361 | 81.36M |
| 216 | RIGL | Rigel Pharmaceuticals, Inc. | 487.14M | 0.30% | 179,068 | 294.28M |
| 217 | KYTX | Kyverna Therapeutics, Inc. | 485.33M | 2.03% | 515,185 | - |
| 218 | NAUT | Nautilus Biotechnology, Inc. | 477.43M | -3.32% | 453,990 | - |
| 219 | TRDA | Entrada Therapeutics, Inc. | 471.28M | 2.16% | 138,477 | 25.42M |
| 220 | LYEL | Lyell Immunopharma, Inc. | 471.27M | 0.40% | 49,609 | 36.00K |
| 221 | ENGN | enGene Holdings Inc. | 466.25M | -1.56% | 115,571 | - |
| 222 | VSTM | Verastem, Inc. | 464.65M | 3.93% | 1,872,692 | 30.91M |
| 223 | FULC | Fulcrum Therapeutics, Inc. | 462.21M | -0.57% | 342,530 | 80.00M |
| 224 | IMMX | Immix Biopharma, Inc. | 461.85M | -2.13% | 1,045,473 | - |
| 225 | ASMB | Assembly Biosciences, Inc. | 457.96M | 0.70% | 65,234 | 72.30M |
| 226 | MRVI | Maravai LifeSciences Holdings, Inc. | 452.32M | -0.64% | 695,526 | 185.74M |
| 227 | STTK | Shattuck Labs, Inc. | 451.57M | -0.94% | 425,989 | 1.00M |
| 228 | ABSI | Absci Corporation | 440.70M | -1.37% | 3,645,380 | 2.80M |
| 229 | IVVD | Invivyd, Inc. | 426.72M | -3.21% | 1,564,706 | 53.43M |
| 230 | RGNX | REGENXBIO Inc. | 426.32M | -2.36% | 586,837 | 170.44M |
| 231 | AVIR | Atea Pharmaceuticals, Inc. | 424.65M | -1.84% | 252,000 | - |
| 232 | ACRS | Aclaris Therapeutics, Inc. | 424.50M | -1.95% | 1,500,822 | 7.83M |
| 233 | VNDA | Vanda Pharmaceuticals Inc. | 420.85M | -1.79% | 902,933 | 216.11M |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 419.28M | -3.25% | 97,230 | - |
| 235 | ALT | Altimmune, Inc. | 416.22M | -3.32% | 2,191,363 | 41.00K |
| 236 | NMRA | Neumora Therapeutics, Inc. | 416.05M | -0.40% | 1,087,795 | - |
| 237 | STRO | Sutro Biopharma, Inc. | 412.69M | 6.02% | 201,840 | 102.48M |
| 238 | LXEO | Lexeo Therapeutics, Inc. | 412.38M | -1.22% | 800,975 | - |
| 239 | AURA | Aura Biosciences, Inc. | 408.96M | -0.62% | 245,126 | - |
| 240 | XFOR | X4 Pharmaceuticals, Inc. | 391.86M | 5.38% | 655,025 | 35.11M |
| 241 | LCTX | Lineage Cell Therapeutics, Inc. | 381.10M | -1.29% | 650,421 | 14.56M |
| 242 | PRTC | PureTech Health plc | 378.40M | -1.01% | 1,135 | 6.39M |
| 243 | DNA | Ginkgo Bioworks Holdings, Inc. | 377.71M | -12.91% | 1,134,273 | 170.16M |
| 244 | CBIO | Crescent Biopharma, Inc. | 372.02M | 14.60% | 449,024 | 10.84M |
| 245 | BNTC | Benitec Biopharma Inc. | 371.37M | -0.28% | 86,764 | - |
| 246 | IPSC | Century Therapeutics, Inc. | 370.23M | -0.48% | 1,114,567 | 109.16M |
| 247 | MNPR | Monopar Therapeutics Inc. | 364.60M | -4.20% | 125,424 | - |
| 248 | XOMA | XOMA Royalty Corporation | 363.90M | 1.21% | 100,943 | 52.15M |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 363.03M | 2.79% | 158,355 | 66.98M |
| 250 | NAGE | Niagen Bioscience, Inc. | 357.96M | -1.11% | 934,260 | 129.42M |
| 251 | CADL | Candel Therapeutics, Inc. | 357.45M | -2.20% | 1,116,695 | - |
| 252 | DMAC | DiaMedica Therapeutics Inc. | 356.73M | -0.15% | 164,898 | - |
| 253 | GLSI | Greenwich LifeSciences, Inc. | 351.07M | -2.50% | 103,173 | - |
| 254 | AUTL | Autolus Therapeutics plc | 343.32M | -3.01% | 2,379,703 | 51.13M |
| 255 | ARMP | Armata Pharmaceuticals, Inc. | 342.52M | 8.59% | 48,830 | 4.90M |
| 256 | CLYM | Climb Bio, Inc. | 339.63M | 1.86% | 413,617 | - |
| 257 | FBRX | Forte Biosciences, Inc. | 338.35M | 2.39% | 436,447 | - |
| 258 | PEPG | PepGen Inc. | 337.97M | 0.20% | 677,324 | - |
| 259 | IMRX | Immuneering Corporation | 337.49M | -1.88% | 457,859 | - |
| 260 | NGNE | Neurogene Inc. | 333.45M | -2.81% | 95,615 | 925.00K |
| 261 | PALI | Palisade Bio, Inc. | 325.13M | -2.00% | 3,980,239 | - |
| 262 | OVID | Ovid Therapeutics Inc. | 324.41M | 2.50% | 1,564,490 | 7.25M |
| 263 | SRZN | Surrozen, Inc. | 321.63M | 7.12% | 58,112 | 3.48M |
| 264 | IRD | Opus Genetics, Inc. | 321.59M | -4.84% | 418,714 | 14.20M |
| 265 | PBYI | Puma Biotechnology, Inc. | 319.00M | -0.95% | 180,173 | 228.37M |
| 266 | AVTX | Avalo Therapeutics, Inc. | 317.90M | - | 838,671 | 59.00K |
| 267 | CABA | Cabaletta Bio, Inc. | 313.93M | 1.44% | 1,347,878 | - |
| 268 | BCYC | Bicycle Therapeutics plc | 313.68M | -3.85% | 784,545 | 72.59M |
| 269 | RZLT | Rezolute, Inc. | 311.02M | 2.20% | 5,556,862 | - |
| 270 | PLYX | Polaryx Therapeutics, Inc. | 302.05M | 1.59% | 232,106 | - |
| 271 | ACIU | AC Immune SA | 294.13M | -1.70% | 128,064 | 4.51M |
| 272 | NBP | NovaBridge Biosciences | 293.99M | -3.41% | 450,382 | - |
| 273 | FHTX | Foghorn Therapeutics Inc. | 287.63M | -0.61% | 128,470 | 30.91M |
| 274 | TARA | Protara Therapeutics, Inc. | 280.70M | -2.26% | 501,419 | - |
| 275 | LENZ | LENZ Therapeutics, Inc. | 280.31M | -1.43% | 2,036,436 | 19.09M |
| 276 | ALXO | ALX Oncology Holdings Inc. | 268.48M | - | 433,045 | - |
| 277 | AVXL | Anavex Life Sciences Corp. | 266.89M | 5.11% | 3,595,454 | - |
| 278 | NERV | Minerva Neurosciences, Inc. | 265.70M | 0.66% | 325,986 | - |
| 279 | OBIO | Orchestra BioMed Holdings, Inc. | 263.05M | -1.64% | 111,609 | 33.48M |
| 280 | ENLV | Enlivex Ltd. | 258.75M | -9.17% | 780,378 | - |
| 281 | TENX | Tenax Therapeutics, Inc. | 257.45M | 6.93% | 382,307 | - |
| 282 | CCCC | C4 Therapeutics, Inc. | 255.65M | -2.60% | 1,638,771 | 35.95M |
| 283 | PROK | ProKidney Corp. | 251.24M | -3.28% | 854,257 | 893.00K |
| 284 | SLN | Silence Therapeutics plc | 250.81M | -2.93% | 307,104 | 559.00K |
| 285 | CHRS | Coherus Oncology, Inc. | 248.82M | -6.21% | 564,644 | 42.17M |
| 286 | ABEO | Abeona Therapeutics Inc. | 247.02M | -2.04% | 1,281,383 | 5.82M |
| 287 | VYGR | Voyager Therapeutics, Inc. | 246.15M | 2.48% | 414,601 | 40.37M |
| 288 | CLLS | Cellectis S.A. | 238.62M | -4.60% | 15,086 | 79.59M |
| 289 | CAMP | Camp4 Therapeutics Corporation | 236.75M | -4.00% | 113,858 | 3.50M |
| 290 | ALEC | Alector, Inc. | 233.97M | -2.30% | 378,178 | 21.05M |
| 291 | CNTX | Context Therapeutics Inc. | 233.37M | -4.87% | 741,155 | - |
| 292 | HELP | Cybin Inc. | 232.67M | -2.11% | 1,503,878 | - |
| 293 | OABI | OmniAb, Inc. | 228.76M | -2.47% | 153,460 | 18.67M |
| 294 | EDIT | Editas Medicine, Inc. | 227.06M | - | 1,703,988 | 40.52M |
| 295 | ELDN | Eledon Pharmaceuticals, Inc. | 224.52M | 1.37% | 963,917 | - |
| 296 | KROS | Keros Therapeutics, Inc. | 218.47M | -2.29% | 385,791 | 244.06M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 217.07M | -1.47% | 63,632 | 19.39M |
| 298 | IKT | Inhibikase Therapeutics, Inc. | 215.21M | - | 544,493 | 1.00 |
| 299 | NVCT | Nuvectis Pharma, Inc. | 206.90M | -1.88% | 35,126 | - |
| 300 | CNTB | Connect Biopharma Holdings Limited | 206.28M | 9.82% | 618,598 | 762.00K |
| 301 | PRLD | Prelude Therapeutics Incorporated | 204.13M | -0.61% | 52,480 | 12.14M |
| 302 | MGNX | MacroGenics, Inc. | 202.11M | 0.32% | 883,282 | 149.50M |
| 303 | MDWD | MediWound Ltd. | 201.64M | -7.48% | 223,346 | 16.96M |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 201.24M | 0.28% | 407,685 | 82.03M |
| 305 | ELTX | Elicio Therapeutics, Inc. | 199.05M | -1.28% | 88,886 | - |
| 306 | SABS | SAB Biotherapeutics, Inc. | 195.14M | 0.26% | 649,780 | 114.70K |
| 307 | ADAG | Adagene Inc. | 195.12M | 1.72% | 199,039 | 103.20K |
| 308 | CGEN | Compugen Ltd. | 194.78M | - | 125,474 | 72.76M |
| 309 | ZNTL | Zentalis Pharmaceuticals, Inc. | 189.39M | 4.71% | 412,809 | 26.87M |
| 310 | CRBU | Caribou Biosciences, Inc. | 184.58M | 1.60% | 1,084,772 | 11.16M |
| 311 | TNXP | Tonix Pharmaceuticals Holding Corp. | 184.32M | -8.33% | 408,225 | 13.11M |
| 312 | FENC | Fennec Pharmaceuticals Inc. | 183.04M | 5.51% | 463,511 | 44.64M |
| 313 | GALT | Galectin Therapeutics Inc. | 180.52M | -4.44% | 186,468 | - |
| 314 | PLX | Protalix BioTherapeutics, Inc. | 169.69M | -2.31% | 951,603 | 52.74M |
| 315 | WHWK | Whitehawk Therapeutics, Inc. | 168.49M | -0.56% | 166,702 | 7.15M |
| 316 | SGMT | Sagimet Biosciences Inc. | 166.51M | 10.61% | 588,993 | - |
| 317 | NTHI | NeOnc Technologies Holdings, Inc. | 165.20M | 2.82% | 26,987 | 59.99K |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 164.86M | -7.78% | 471,114 | - |
| 319 | IMUX | Immunic, Inc. | 164.39M | -4.55% | 1,529,472 | - |
| 320 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 163.88M | 11.19% | 294,492 | - |
| 321 | DTIL | Precision BioSciences, Inc. | 161.71M | 1.08% | 237,804 | 34.26M |
| 322 | RNAC | Cartesian Therapeutics, Inc. | 161.17M | -2.72% | 133,563 | 2.80M |
| 323 | MOLN | Molecular Partners AG | 160.83M | -0.26% | 1,111 | 856.30K |
| 324 | PRQR | ProQR Therapeutics N.V. | 158.04M | -5.06% | 226,959 | 19.19M |
| 325 | KRRO | Korro Bio, Inc. | 157.35M | -0.09% | 121,472 | 6.39M |
| 326 | HRTX | Heron Therapeutics, Inc. | 155.56M | 3.62% | 7,261,241 | 154.90M |
| 327 | ABOS | Acumen Pharmaceuticals, Inc. | 154.46M | -3.04% | 710,633 | - |
| 328 | ACHV | Achieve Life Sciences, Inc. | 153.86M | 2.48% | 974,422 | - |
| 329 | NKTX | Nkarta, Inc. | 152.56M | 0.47% | 556,361 | - |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 152.09M | -2.98% | 3,374,361 | - |
| 331 | CDXS | Codexis, Inc. | 150.84M | -5.14% | 663,772 | 70.39M |
| 332 | MENS | Jyong Biotech Ltd. | 149.95M | -3.35% | 39,009 | - |
| 333 | EVAX | Evaxion A/S | 149.71M | -2.97% | 18,198 | 7.53M |
| 334 | VTVT | vTv Therapeutics Inc. | 148.88M | -1.31% | 19,420 | 17.00K |
| 335 | CBUS | Cibus, Inc. | 147.39M | -25.78% | 2,654,336 | 3.64M |
| 336 | HUMA | Humacyte, Inc. | 145.77M | -5.42% | 6,715,516 | 1.57M |
| 337 | FATE | Fate Therapeutics, Inc. | 143.00M | 0.82% | 1,147,154 | 6.65M |
| 338 | UNCY | Unicycive Therapeutics, Inc. | 142.49M | -0.30% | 239,148 | - |
| 339 | VOR | Vor Biopharma Inc. | 141.27M | 4.87% | 947,316 | - |
| 340 | MIST | Milestone Pharmaceuticals Inc. | 141.05M | -8.00% | 1,391,613 | 1.55M |
| 341 | SPRO | Spero Therapeutics, Inc. | 137.20M | -1.66% | 393,328 | 40.55M |
| 342 | PMN | ProMIS Neurosciences, Inc. | 135.68M | -4.54% | 32,096 | - |
| 343 | ORMP | Oramed Pharmaceuticals Inc. | 133.88M | -5.43% | 107,964 | 2.00M |
| 344 | RANI | Rani Therapeutics Holdings, Inc. | 133.59M | -5.26% | 2,342,477 | 1.20M |
| 345 | KLRS | Kalaris Therapeutics, Inc. | 133.44M | -4.82% | 100,435 | - |
| 346 | AGEN | Agenus Inc. | 132.09M | -3.37% | 244,952 | 114.20M |
| 347 | EQ | Equillium, Inc. | 130.25M | - | 349,196 | 4.39M |
| 348 | ANTX | AN2 Therapeutics, Inc. | 129.75M | -1.37% | 321,534 | - |
| 349 | ARTV | Artiva Biotherapeutics, Inc. | 127.54M | -5.49% | 106,733 | 251.00K |
| 350 | BDTX | Black Diamond Therapeutics, Inc. | 122.03M | -2.74% | 663,140 | 70.00M |
| 351 | GNLX | Genelux Corporation | 117.84M | -0.75% | 160,460 | 8.00K |
| 352 | IPHA | Innate Pharma S.A. | 117.15M | -2.34% | 28,876 | 10.57M |
| 353 | ACOG | Alpha Cognition Inc. | 116.10M | 0.38% | 59,677 | 7.43M |
| 354 | SGMO | Sangamo Therapeutics, Inc. | 115.79M | -2.11% | 5,101,586 | 32.88M |
| 355 | CRDF | Cardiff Oncology, Inc. | 114.17M | -3.47% | 584,879 | 593.00K |
| 356 | ALDX | Aldeyra Therapeutics, Inc. | 110.74M | -0.54% | 2,975,776 | - |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 107.09M | 0.65% | 381,670 | 65.34K |
| 358 | QTTB | Q32 Bio Inc. | 104.45M | -1.52% | 346,266 | 53.74M |
| 359 | KPTI | Karyopharm Therapeutics Inc. | 102.18M | 6.91% | 4,104,597 | 146.07M |
| 360 | TTRX | Turn Therapeutics Inc. | 100.11M | -0.29% | 41,108 | - |
| 361 | HURA | TuHURA Biosciences, Inc. | 99.95M | -2.01% | 428,738 | - |
| 362 | BMEA | Biomea Fusion, Inc. | 99.05M | 12.30% | 2,866,089 | - |
| 363 | COYA | Coya Therapeutics, Inc. | 98.05M | -0.36% | 118,575 | 7.95M |
| 364 | ONCY | Oncolytics Biotech Inc. | 96.95M | -5.16% | 863,865 | - |
| 365 | CGTX | Cognition Therapeutics, Inc. | 96.50M | -2.70% | 1,778,625 | - |
| 366 | SEER | Seer, Inc. | 95.07M | -2.32% | 121,515 | 16.58M |
| 367 | SPRB | Spruce Biosciences, Inc. | 94.82M | -1.23% | 41,096 | 697.00K |
| 368 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 91.59M | -5.40% | 441,370 | - |
| 369 | VANI | Vivani Medical, Inc. | 91.42M | -4.42% | 271,247 | - |
| 370 | MCRB | Seres Therapeutics, Inc. | 89.44M | 2.08% | 22,820 | 789.00K |
| 371 | FBIO | Fortress Biotech, Inc. | 89.39M | -3.68% | 700,793 | 62.30M |
| 372 | ANIX | Anixa Biosciences, Inc. | 88.18M | -2.59% | 100,309 | - |
| 373 | GOSS | Gossamer Bio, Inc. | 87.96M | -1.76% | 8,563,040 | 48.47M |
| 374 | PYXS | Pyxis Oncology, Inc. | 86.71M | -3.50% | 180,511 | 13.86M |
| 375 | MAIA | MAIA Biotechnology, Inc. | 83.73M | -6.12% | 1,245,076 | - |
| 376 | CSBR | Champions Oncology, Inc. | 80.40M | -0.17% | 8,004 | 57.95M |
| 377 | KZIA | Kazia Therapeutics Limited | 79.92M | 0.48% | 91,826 | 1.27M |
| 378 | NRXP | NRx Pharmaceuticals, Inc. | 78.70M | -1.24% | 991,855 | 1.23M |
| 379 | PYPD | PolyPid Ltd. | 78.64M | 0.70% | 49,202 | - |
| 380 | NRXS | NeurAxis, Inc. | 78.31M | -6.79% | 118,273 | 3.57M |
| 381 | ATYR | aTyr Pharma, Inc. | 77.73M | -0.83% | 624,308 | 190.00K |
| 382 | AARD | Aardvark Therapeutics, Inc. | 76.57M | -0.85% | 263,633 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 76.31M | 2.94% | 7,938 | 16.80M |
| 384 | PLRX | Pliant Therapeutics, Inc. | 76.16M | -6.11% | 634,645 | - |
| 385 | GUTS | Fractyl Health, Inc. | 75.07M | -5.36% | 1,896,425 | 3.00K |
| 386 | VRCA | Verrica Pharmaceuticals Inc. | 74.99M | -5.52% | 94,009 | 35.58M |
| 387 | GRCE | Grace Therapeutics, Inc. | 73.81M | 1.71% | 795,812 | - |
| 388 | CING | Cingulate Inc. | 73.03M | -1.26% | 303,526 | - |
| 389 | PMVP | PMV Pharmaceuticals, Inc. | 71.99M | -1.46% | 971,499 | - |
| 390 | XBIT | XBiotech Inc. | 70.43M | -2.12% | 26,597 | - |
| 391 | MNOV | MediciNova, Inc. | 69.65M | -3.08% | 29,887 | 409.66K |
| 392 | DWTX | Dogwood Therapeutics, Inc. | 69.48M | -9.96% | 78,202 | - |
| 393 | GANX | Gain Therapeutics, Inc. | 68.22M | -3.57% | 453,702 | - |
| 394 | COEP | Coeptis Therapeutics Holdings, Inc. | 67.96M | -2.41% | 20,622 | 1.36M |
| 395 | IFRX | InflaRx N.V. | 67.23M | -1.10% | 387,920 | 34.44K |
| 396 | BYSI | BeyondSpring Inc. | 66.20M | -4.17% | 32,613 | 1.88M |
| 397 | ACET | Adicet Bio, Inc. | 64.58M | -1.17% | 63,974 | - |
| 398 | OKUR | OnKure Therapeutics, Inc. | 62.76M | 14.75% | 643,267 | - |
| 399 | ANVS | Annovis Bio, Inc. | 60.96M | -3.15% | 452,756 | - |
| 400 | IBO | Impact BioMedical Inc. | 60.89M | -3.11% | 133,453 | 32.00K |
| 401 | EXOZ | eXoZymes, Inc. | 60.64M | 0.42% | 5,075 | -700.00 |
| 402 | IBIO | iBio, Inc. | 60.11M | -20.18% | 6,199,760 | 300.00K |
| 403 | ICCC | ImmuCell Corporation | 59.07M | 1.40% | 7,685 | 27.64M |
| 404 | TCRX | TScan Therapeutics, Inc. | 58.61M | -0.96% | 290,125 | 10.33M |
| 405 | HYFT | MindWalk Holdings Corp. | 57.61M | -4.92% | 146,220 | 20.70M |
| 406 | IMA | ImageneBio, Inc. | 57.53M | -2.88% | 3,832 | 800.00K |
| 407 | ATHE | Alterity Therapeutics Limited | 57.28M | -7.33% | 9,298 | 4.43M |
| 408 | TIL | Instil Bio, Inc. | 56.22M | -3.60% | 26,830 | - |
| 409 | ACRV | Acrivon Therapeutics, Inc. | 55.02M | -6.58% | 863,072 | - |
| 410 | LPCN | Lipocine Inc. | 54.13M | -0.20% | 31,605 | 1.98M |
| 411 | MREO | Mereo BioPharma Group plc | 54.09M | -3.12% | 879,210 | 500.00K |
| 412 | IMMP | Immutep Limited | 52.86M | -2.15% | 577,944 | 5.28M |
| 413 | ACTU | Actuate Therapeutics, Inc. | 52.76M | -2.16% | 40,459 | - |
| 414 | MGX | Metagenomi Therapeutics, Inc. | 52.29M | - | 150,726 | 25.21M |
| 415 | RADX | Radiopharm Theranostics Limited | 50.21M | -1.85% | 110,743 | 10.86M |
| 416 | XLO | Xilio Therapeutics, Inc. | 50.19M | 1.76% | 58,838 | 43.77M |
| 417 | EDSA | Edesa Biotech, Inc. | 48.92M | -10.81% | 786,993 | - |
| 418 | OSTX | OS Therapies Incorporated | 48.24M | -4.86% | 207,852 | - |
| 419 | ENTX | Entera Bio Ltd. | 47.23M | -12.71% | 260,225 | 124.00K |
| 420 | KZR | Kezar Life Sciences, Inc. | 46.50M | -2.01% | 21,931 | - |
| 421 | NTRB | Nutriband Inc. | 46.33M | 1.32% | 12,643 | 2.28M |
| 422 | LSTA | Lisata Therapeutics, Inc. | 45.34M | 0.20% | 6,279 | 170.00K |
| 423 | INKT | MiNK Therapeutics, Inc. | 45.20M | 5.53% | 64,035 | - |
| 424 | DCOY | Decoy Therapeutics Inc. | 44.82M | -4.42% | 18,281 | - |
| 425 | RLYB | Rallybio Corporation | 44.59M | -2.26% | 74,816 | 858.00K |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 43.32M | -5.26% | 72,240 | - |
| 427 | ALGS | Aligos Therapeutics, Inc. | 43.25M | 0.43% | 57,917 | 2.19M |
| 428 | RNXT | RenovoRx, Inc. | 42.51M | 5.45% | 1,458,071 | 928.00K |
| 429 | GOVX | GeoVax Labs, Inc. | 42.38M | -6.00% | 57,411 | 3.35M |
| 430 | LITS | Lite Strategy, Inc. | 42.18M | -3.33% | 154,489 | - |
| 431 | HOWL | Werewolf Therapeutics, Inc. | 41.90M | 10.63% | 324,429 | 1.14M |
| 432 | PSTV | Plus Therapeutics, Inc. | 41.67M | -1.22% | 2,095,901 | 5.21M |
| 433 | NBY | NovaBay Pharmaceuticals, Inc. | 40.74M | 7.75% | 362,487 | 10.30M |
| 434 | ATOS | Atossa Therapeutics, Inc. | 40.56M | -13.10% | 123,565 | - |
| 435 | ESLA | Estrella Immunopharma, Inc. | 39.28M | 6.10% | 96,193 | - |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 38.52M | -5.04% | 67,036 | 120.77M |
| 437 | LONA | LeonaBio, Inc. | 38.18M | 7.20% | 125,933 | - |
| 438 | APLM | Apollomics, Inc. | 37.84M | -1.37% | 4,512 | 6.93M |
| 439 | CRVO | CervoMed Inc. | 36.29M | -2.97% | 31,980 | 4.01M |
| 440 | PTN | Palatin Technologies, Inc. | 36.24M | -1.67% | 5,869 | 8.96M |
| 441 | NXTC | NextCure, Inc. | 36.07M | -0.59% | 31,536 | - |
| 442 | VERU | Veru Inc. | 35.79M | -2.62% | 46,375 | 16.89M |
| 443 | CELU | Celularity Inc. | 34.61M | -0.83% | 45,146 | 40.58M |
| 444 | SNSE | Sensei Biotherapeutics, Inc. | 33.91M | -8.85% | 76,150 | - |
| 445 | RNTX | Rein Therapeutics Inc. | 33.38M | -2.31% | 116,242 | - |
| 446 | PLUR | Pluri Inc. | 33.07M | -1.20% | 11,348 | 1.34M |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 32.76M | -2.78% | 96,007 | 90.00K |
| 448 | SER | Serina Therapeutics, Inc. | 32.14M | -13.86% | 923,643 | 130.00K |
| 449 | INMB | INmune Bio Inc. | 31.90M | -1.64% | 223,571 | 50.00K |
| 450 | PDSB | PDS Biotechnology Corporation | 31.35M | 0.85% | 424,039 | - |
| 451 | TVRD | Tvardi Therapeutics, Inc. | 31.24M | 1.22% | 29,055 | - |
| 452 | JSPR | Jasper Therapeutics, Inc. | 31.06M | 1.83% | 401,318 | - |
| 453 | TLSA | Tiziana Life Sciences Ltd | 29.71M | -7.41% | 136,089 | - |
| 454 | XCUR | Exicure, Inc. | 29.38M | - | 9,664 | 500.00K |
| 455 | CVM | CEL-SCI Corporation | 29.35M | -1.70% | 41,986 | - |
| 456 | HYPD | Hyperion DeFi, Inc. | 28.26M | -5.68% | 232,487 | 813.46K |
| 457 | BCTX | BriaCell Therapeutics Corp. | 28.17M | -3.95% | 138,429 | - |
| 458 | ABVC | ABVC BioPharma, Inc. | 26.71M | -2.78% | 41,359 | 797.92K |
| 459 | KYNB | Kyntra Bio, Inc. | 26.47M | -3.68% | 26,345 | 6.44M |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 25.88M | 0.64% | 63,027 | - |
| 461 | DYAI | Dyadic International, Inc. | 25.55M | -19.63% | 238,478 | 3.09M |
| 462 | BOLD | Boundless Bio, Inc. | 24.87M | -1.77% | 51,180 | - |
| 463 | CUE | Cue Biopharma, Inc. | 24.50M | -5.03% | 631,702 | 27.47M |
| 464 | IGC | IGC Pharma, Inc. | 24.18M | -0.61% | 235,617 | 1.11M |
| 465 | VTGN | Vistagen Therapeutics, Inc. | 23.96M | -0.90% | 381,234 | 789.00K |
| 466 | LTRN | Lantern Pharma Inc. | 23.38M | -5.86% | 31,808 | - |
| 467 | CRIS | Curis, Inc. | 23.19M | -17.15% | 1,265,320 | 9.44M |
| 468 | XTLB | XTL Biopharmaceuticals Ltd. | 23.18M | -2.95% | 18,160 | 968.00K |
| 469 | SNTI | Senti Biosciences, Inc. | 23.17M | 0.03% | 52,680 | - |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 22.64M | -3.89% | 19,454 | 14.99M |
| 471 | LGVN | Longeveron Inc. | 22.64M | -0.02% | 530,825 | 1.20M |
| 472 | MRKR | Marker Therapeutics, Inc. | 22.51M | 0.75% | 80,786 | 3.55M |
| 473 | BRNS | Barinthus Biotherapeutics plc | 22.46M | -0.04% | 5,491 | 14.97M |
| 474 | TPST | Tempest Therapeutics, Inc. | 22.38M | -4.60% | 1,061,722 | - |
| 475 | QNTM | Quantum BioPharma Ltd. | 22.17M | -11.95% | 280,076 | - |
| 476 | PLRZ | Polyrizon Ltd. | 22.11M | -3.37% | 8,964 | - |
| 477 | PASG | Passage Bio, Inc. | 22.07M | -3.03% | 9,194 | - |
| 478 | DARE | Daré Bioscience, Inc. | 21.98M | 7.86% | 187,332 | -57.13K |
| 479 | NNVC | NanoViricides, Inc. | 20.74M | 1.44% | 171,602 | - |
| 480 | SKYE | Skye Bioscience, Inc. | 20.63M | -1.09% | 185,933 | - |
| 481 | VYNE | VYNE Therapeutics Inc. | 20.40M | 0.23% | 250,683 | 570.00K |
| 482 | LEXX | Lexaria Bioscience Corp. | 18.68M | -3.15% | 251,791 | 522.00K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 17.96M | -0.42% | 59,070 | - |
| 484 | OTLK | Outlook Therapeutics, Inc. | 17.44M | 0.96% | 4,226,291 | 205.70K |
| 485 | ALLR | Allarity Therapeutics, Inc. | 16.92M | -4.46% | 84,552 | - |
| 486 | LIXT | Lixte Biotechnology Holdings, Inc. | 16.91M | -0.84% | 76,313 | - |
| 487 | GNTA | Genenta Science S.p.A. | 15.85M | 10.36% | 52,696 | - |
| 488 | TRAW | Traws Pharma, Inc. | 15.82M | -1.00% | 15,001 | 2.85M |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 15.53M | -3.58% | 153,855 | 3.94M |
| 490 | INTS | Intensity Therapeutics, Inc. | 15.48M | -4.23% | 11,562 | - |
| 491 | FBLG | FibroBiologics, Inc. | 14.87M | -16.51% | 2,250,895 | - |
| 492 | IOBT | IO Biotech, Inc. | 14.75M | 6.33% | 936,478 | - |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 14.64M | - | 423,549 | - |
| 494 | INAB | IN8bio, Inc. | 14.48M | -8.70% | 77,316 | - |
| 495 | COCP | Cocrystal Pharma, Inc. | 14.20M | -4.63% | 30,117 | - |
| 496 | GTBP | GT Biopharma, Inc. | 14.07M | -4.09% | 401,978 | - |
| 497 | AEON | AEON Biopharma, Inc. | 13.80M | -1.96% | 109,124 | - |
| 498 | HOTH | Hoth Therapeutics, Inc. | 13.01M | -6.65% | 321,116 | - |
| 499 | MBRX | Moleculin Biotech, Inc. | 12.97M | -2.41% | 109,780 | - |
| 500 | BCDA | BioCardia, Inc. | 12.91M | -1.67% | 18,818 | 3.00K |